Quantcast
Sunday, June 23, 2024

Pfizer Plotting COVID Mutations to Enrich Vax Profits

'COVID is going to be a cash cow for us for a while going forward. Like obviously... '

(Mark Pellin, Headline USA) A Pfizer research director said the quiet part out loud, admitting to an undercover reporter that the Big Pharma titan is exploring ways to “mutate” the coronavirus using “directed evolution” to corner the future market of vaccine production.

“One of the things we’re exploring is like, why don’t we just mutate it [COVID] ourselves so we could create — preemptively develop new vaccines, right? So, we have to do that,” Jordon Trishton Walker, Pfizer director of research and development with strategic operations and mRNA scientific planning told an undercover reporter from Project Veritas.

“If we’re gonna do that though, there’s a risk of like, as you could imagine — no one wants to be having a pharma company mutating f**king viruses.”

In that light, the Pfizer executive implored the journalist to keep the secret under wraps.

“Don’t tell anyone. Promise you won’t tell anyone,” Walker demanded. “The way it [the experiment] would work is that we put the virus in monkeys, and we successively cause them to keep infecting each other, and we collect serial samples from them.”

Pfizer is exploring ways to take controversial gain-of-function enhancements to the next level, through what was termed “directed evolution,” according to Walker.

“From what I’ve heard is they [Pfizer scientists] are optimizing it [COVID mutation process], but they’re going slow because everyone is very cautious — obviously they don’t want to accelerate it too much,” he said. “I think they are also just trying to do it as an exploratory thing because you obviously don’t want to advertise that you are figuring out future mutations.”

The Pfizer strategic operations executive also referenced the Wuhan lab, where mounting evidence indicates that COVID originated there and spread through a leak.

“You have to be very controlled to make sure that this virus that you mutate doesn’t create something that just goes everywhere,” Walker warned. ‘Which, I suspect, is the way that the virus started in Wuhan, to be honest. It makes no sense that this virus popped out of nowhere. It’s bulls—t.”

At the same time, Walker conceded that gain-of-function and its offshoot “directed evolution” research carry inherent risk.

“You’re not supposed to do gain-of-function research with viruses. Really not. We can do these selected structure mutations to make them more potent,” he said. “There is research ongoing about that. I don’t know how that is going to work. There better not be any more outbreaks because Jesus Christ.”

Dr. Robert Malone blistered Pfizer for its reported recklessness, telling Project Veritas that the company’s executive “seems to have absolutely no moral compass, at all.”

“If this is the quality of individuals within Pfizer that are making these huge decisions that risk global public health, with such a casual disregard for the human toll it’s profoundly corrupt,” Malone said.

The public shouldn’t count on the government’s help thwarting Pfizer’s plots, largely because regime agents are already safely in Big Pharm’s pocket, according to Walker, who called the industry “a revolving door for all government officials.”

“So, in the pharma industry, all the people who review our drugs — eventually most of them will come work for pharma companies,” Walker said. “It’s pretty good for the industry to be honest. It’s bad for everybody else in America.”

Pfizer was caught short when the Delta and Omicron variants hit, costing them revenue before they had a vax in place, and didn’t plan to be blindsided again, Walker said.

“Either way, it’s going to be a cash cow. COVID is going to be a cash cow for us for a while going forward,” he boasted. “Like obviously.”

“Well, I think the whole research of the viruses and mutating it, like, would be the ultimate cash cow,” the journalist added.

“Yeah, it’d be perfect,” Walker agreed.

Copyright 2024. No part of this site may be reproduced in whole or in part in any manner other than RSS without the permission of the copyright owner. Distribution via RSS is subject to our RSS Terms of Service and is strictly enforced. To inquire about licensing our content, use the contact form at https://headlineusa.com/advertising.
- Advertisement -

TRENDING NOW

TRENDING NOW